211 related articles for article (PubMed ID: 9108922)
1. Use of the urine cortisol: creatinine ratio to monitor treatment response in dogs with pituitary-dependent hyperadrenocorticism.
Guptill L; Scott-Moncrieff JC; Bottoms G; Glickman L; Johnson M; Glickman N; Nelson R; Bertoy E
J Am Vet Med Assoc; 1997 Apr; 210(8):1158-61. PubMed ID: 9108922
[TBL] [Abstract][Full Text] [Related]
2. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
[TBL] [Abstract][Full Text] [Related]
3. Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
Angles JM; Feldman EC; Nelson RW; Feldman MS
J Am Vet Med Assoc; 1997 Oct; 211(8):1002-4. PubMed ID: 9343543
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of urine protein content in dogs with pituitary-dependent hyperadrenocorticism.
Hurley KJ; Vaden SL
J Am Vet Med Assoc; 1998 Feb; 212(3):369-73. PubMed ID: 9470045
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of urinary cortisol:creatinine ratios for the diagnosis of hyperadrenocorticism associated with adrenal gland tumors in ferrets.
Gould WJ; Reimers TJ; Bell JA; Lawrence HJ; Randolph JF; Rowland PH; Scarlett JM
J Am Vet Med Assoc; 1995 Jan; 206(1):42-6. PubMed ID: 7744661
[TBL] [Abstract][Full Text] [Related]
6. Urinary glucocorticoid excretion in the diagnosis of hyperadrenocorticism in ferrets.
Schoemaker NJ; Wolfswinkel J; Mol JA; Voorhout G; Kik MJ; Lumeij JT; Rijnberk A
Domest Anim Endocrinol; 2004 Jul; 27(1):13-24. PubMed ID: 15158531
[TBL] [Abstract][Full Text] [Related]
7. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
Feldman EC; Nelson RW; Feldman MS; Farver TB
J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
[TBL] [Abstract][Full Text] [Related]
8. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs.
Kaplan AJ; Peterson ME; Kemppainen RJ
J Am Vet Med Assoc; 1995 Aug; 207(4):445-51. PubMed ID: 7591942
[TBL] [Abstract][Full Text] [Related]
9. Systemic arterial blood pressure and urine protein/creatinine ratio in dogs with hyperadrenocorticism.
Ortega TM; Feldman EC; Nelson RW; Willits N; Cowgill LD
J Am Vet Med Assoc; 1996 Nov; 209(10):1724-9. PubMed ID: 8921029
[TBL] [Abstract][Full Text] [Related]
10. ACTH-independent hyperadrenocorticism due to food-dependent hypercortisolemia in a dog: a case report.
Galac S; Kars VJ; Voorhout G; Mol JA; Kooistra HS
Vet J; 2008 Jul; 177(1):141-3. PubMed ID: 17572120
[TBL] [Abstract][Full Text] [Related]
11. Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.
Nelson RW; Feldman EC; Shinsako J
Am J Vet Res; 1985 Jul; 46(7):1534-7. PubMed ID: 2992329
[TBL] [Abstract][Full Text] [Related]
12. A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.
Lee YM; Kang BT; Jung DI; Park C; Kim HJ; Kim JW; Lim CY; Park EH; Park HM
J Vet Sci; 2005 Dec; 6(4):363-6. PubMed ID: 16294004
[TBL] [Abstract][Full Text] [Related]
13. Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms.
Kintzer PP; Peterson ME
J Am Vet Med Assoc; 1994 Jul; 205(1):54-61. PubMed ID: 7928549
[TBL] [Abstract][Full Text] [Related]
14. Urine cortisol:creatinine ratio as a screening test for hyperadrenocorticism in dogs.
Feldman EC; Mack RE
J Am Vet Med Assoc; 1992 Jun; 200(11):1637-41. PubMed ID: 1624338
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the use of baseline cortisol concentration as a monitoring tool for dogs receiving trilostane as a treatment for hyperadrenocorticism.
Cook AK; Bond KG
J Am Vet Med Assoc; 2010 Oct; 237(7):801-5. PubMed ID: 20919845
[TBL] [Abstract][Full Text] [Related]
16. One-year follow-up evaluation of magnetic resonance imaging of the brain in dogs with pituitary-dependent hyperadrenocorticism.
Bertoy EH; Feldman EC; Nelson RW; Dublin AB; Reid MH; Feldman MS
J Am Vet Med Assoc; 1996 Apr; 208(8):1268-73. PubMed ID: 8635969
[TBL] [Abstract][Full Text] [Related]
17. Plasma cortisol response to ketoconazole administration in dogs with hyperadrenocorticism.
Feldman EC; Bruyette DS; Nelson RW; Farver TB
J Am Vet Med Assoc; 1990 Jul; 197(1):71-8. PubMed ID: 2370223
[TBL] [Abstract][Full Text] [Related]
18. Tailored reference limits for urine corticoid:creatinine ratio in dogs to answer distinct clinical questions.
Zeugswetter F; Bydzovsky N; Kampner D; Schwendenwein I
Vet Rec; 2010 Dec; 167(26):997-1001. PubMed ID: 21262729
[TBL] [Abstract][Full Text] [Related]
19. Use of ketoconazole to treat dogs with pituitary-dependent hyperadrenocorticism: 48 cases (1994-2007).
Lien YH; Huang HP
J Am Vet Med Assoc; 2008 Dec; 233(12):1896-901. PubMed ID: 19072605
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of hyperadrenocorticism in dogs as compared to human diagnostic methods: a review.
Thuróczy J; Balogh L; Huszenicza G; Jánoki GA; Kulcsár M
Acta Vet Hung; 1998; 46(2):157-73. PubMed ID: 9704520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
